Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Covington
Moodys
Fuji
Cantor Fitzgerald
Citi
McKinsey
Johnson and Johnson
Baxter
UBS

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,443,432

« Back to Dashboard

Summary for Patent: 4,443,432
Title: Ophthmalic irrigating solution
Abstract:An ophthalmic irrigating solution useful for irrigating the human eye contains sodium, potassium, magnesium, calcium, chloride, and bicarbonate ions as well as dextrose and glutathione in proportions consistent with the osmotic stability and continued metabolism of the endothelial cells. The irrigating solution is prepared by mixing a first basic solution which provides the bicarbonate and a second acidic solution which provides the calcium, magnesium, dextrose and glutathione. The first and second solutions may be stored as stable, sterile solutions for extended periods of time and mixed within 24 hours of use.
Inventor(s): Garabedian; Michael E. (Arlington, TX), Roehrs; Robert E. (Fort Worth, TX)
Assignee: Alcon Laboratories, Inc. (Forth Worth, TX)
Application Number:06/308,386
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 4,443,432

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,443,432

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 228986 ➤ Subscribe
Austria 26398 ➤ Subscribe
Australia 559887 ➤ Subscribe
Australia 8853282 ➤ Subscribe
Canada 1187799 ➤ Subscribe
Germany 3275975 ➤ Subscribe
Denmark 159099 ➤ Subscribe
Denmark 441782 ➤ Subscribe
European Patent Office 0076658 ➤ Subscribe SPC/GB93/155 200210 United Kingdom ➤ Subscribe
Ireland 54082 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Citi
Cipla
Baxter
Teva
QuintilesIMS
McKesson
Dow
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot